2 news items
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
LQDA
13 May 24
our future results of operations and financial position, our strategic and financial initiatives, our business strategy and plans and our objectives
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
LQDA
1 Apr 24
results of operations and financial position, our strategic and financial initiatives, our business strategy and plans and our objectives for future
- Prev
- 1
- Next